Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Stat
RSV
vaccines
elderly
Pfizer
GSK
Flag link:
Heightened US antitrust fears rattle biopharma
Heightened US antitrust fears rattle biopharma
EP Vantage
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Flag link:
GSK to raise $1B by selling partial stake in former consumer health unit Haleon
GSK to raise $1B by selling partial stake in former consumer health unit Haleon
Fierce Pharma
GSK
Haleon
consumer health
Flag link:
GSK tees up Pfizer fight with pivotal meningitis vaccine data
GSK tees up Pfizer fight with pivotal meningitis vaccine data
Fierce Biotech
GSK
Pfizer
vaccines
meningitis
Flag link:
2023’s biggest launches: the story so far
2023’s biggest launches: the story so far
EP Vantage
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Flag link:
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Gilead Sciences
GSK
momelotinib
Roche
Eli Lilly
lebrikizumab
Merck
Zejula
Amgen
Galenica
Veltassa
Cubicin
Flag link:
Iteos – and GSK – keep the faith
Iteos – and GSK – keep the faith
EP Vantage
GSK
iTeos Therapeutics
anti-TIGIT
Roche
belrestotug
Flag link:
Cut Short by RSV: GSK’s compelling ad ties into recent FDA approval
Cut Short by RSV: GSK’s compelling ad ties into recent FDA approval
Medical Marketing and Media
GSK
RSV
vaccines
DTC ads
FDA
Flag link:
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine
Clinical Trials Arena
GSK
CureVac
vaccines
MRNA
Flu
Flag link:
FDA approves first RSV vaccine, clearing GSK’s Arexvy for older adults
FDA approves first RSV vaccine, clearing GSK’s Arexvy for older adults
BioPharma Dive
GSK
RSV
vaccines
Arexvy
FDA
Flag link:
The race for gold: Closing in on the first RSV vaccine
The race for gold: Closing in on the first RSV vaccine
Pharmaphorum
vaccines
RSV
GSK
Pfizer
Moderna Therapeutics
Flag link:
'More in the hopper': European Big Pharmas hint M&A could ramp up
'More in the hopper': European Big Pharmas hint M&A could ramp up
Fierce Biotech
Europe
M&A
GSK
Novartis
Roche
Flag link:
GSK's RSV vaccine first to get EU regulator's nod
GSK's RSV vaccine first to get EU regulator's nod
Reuters
GSK
vaccines
RSV
Europe
Flag link:
As FDA decision nears, GSK projects 'Shingrix-like' sales for its RSV vaccine prospect
As FDA decision nears, GSK projects 'Shingrix-like' sales for its RSV vaccine prospect
Fierce Pharma
GSK
RSV
vaccines
Flag link:
Big pharma holds steady on research spending
Big pharma holds steady on research spending
EP Vantage
R&D
AbbVie
Amgen
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
GSK
JNJ
Merck
Merck KGaA
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
UCB
Vertex Pharmaceuticals
Flag link:
Big pharma’s biggest spenders revealed: 2022 edition
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
Flag link:
GSK faces strike threat in UK, again, after workers pan pay raise
GSK faces strike threat in UK, again, after workers pan pay raise
Fierce Pharma
GSK
UK
strike
Flag link:
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Big Pharma
M&A
Merck
Prometheus Biosciences
GSK
Bellus Health
Flag link:
GSK coughs up $2B for Bellus Health
GSK coughs up $2B for Bellus Health
Medical Marketing and Media
GSK
Bellus Health
M&A
chronic cough
Camlipixant
Flag link:
GSK's gepotidacin shows potential in urinary tract infections
GSK's gepotidacin shows potential in urinary tract infections
Marketscreener
GSK
antibiotics
UTIs
gepotidacin
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »